Mar 27, 2019
Stigmatizing and relegating an activity to the shadows doesn’t improve anyone’s welfare
May 25, 2018
Bill Janeway explains why “efficiency is the enemy of innovation,” and how venture capitalists and the state advance technological change
Oct 5, 2017
The Idea That Businesses Exist Solely to Enrich Shareholders Is Harmful Nonsense
Sep 26, 2017 | 08:15—09:45
Working Paper Series
Conventional wisdom has it that the primary function of the stock market is to raise cash for companies for the purpose of investing in productive capabilities. The conventional wisdom is wrong.
May 15, 2017
A look at America’s strange and dangerous approach to medicine, and how to fix it
Apr 10, 2014
In recent decades, market values have crowded out non- market norms in almost every aspect of life—medicine, education, government, law, art, sports, even family life and personal relations. Without quite realizing it, we have drifted from having a market economy to being a market society. Is this where we want to be?
Apr 12, 2017
Along the entire “innovation chain” — from research and development, to production and commercialization — government and private sectors have very different roles to play.
Feb 10, 2017
Institute scholar Arjun Jayadev argues that while TPP is dead, its damaging legacy on intellectual property rights is likely to shape future bilateral trade agreements
Dec 1, 2016
Flows of goods and services, people and capital have overwhelmed the ability of political processes to accommodate them
Nov 4, 2016
In an Al Jazeera documentary “In Search of the Great American Job”, Institute scholar William Lazonick offers some arch insights into the relationship between financialization — particularly the “shareholder value” ideology in corporations, which drives the transfer of profits to shareholders through stock buybacks — and job creation and inequality.
Oct 27, 2016
Offshoring manufacturing may have hurt many working people in America, but professionals and intellectual property have been robustly protected
Dec 21, 2015
Many Americans have expressed outrage over Pfizer’s plan, through its merger with Allergan, to move its tax home from the United States to Ireland. Now, in a New York Times op-ed, Carl Icahn, the billionaire corporate raider turned hedge fund activist, has joined the chorus. He labels the Pfizer-Allergan deal a “travesty,” blaming the U.S.’s “uncompetitive international tax system.”
Dec 3, 2015
Why are we paying for corporate behavior that crushes innovation, cheats taxpayers, cost jobs, and heightens inequality?
The Innovative Enterprise and the Developmental State: Toward an Economics of “Organizational Success”
Investment in productive capabilities provides the foundation for economic growth.